Structure

InChI Key QBGKPEROWUKSBK-QPPIDDCLSA-N
Smiles CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1
InChI
InChI=1S/C38H48Cl2N4O4S/c1-8-48-33-26-29(36(2,3)4)14-19-32(33)34-41-37(5,27-10-15-30(39)16-11-27)38(6,28-12-17-31(40)18-13-28)44(34)35(45)43-23-21-42(22-24-43)20-9-25-49(7,46)47/h10-19,26H,8-9,20-25H2,1-7H3/t37-,38+/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C38H48Cl2N4O4S
Molecular Weight 727.8
AlogP 7.75
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 9.0
Polar Surface Area 82.52
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 49.0
Assay Description Organism Bioactivity Reference
Cytotoxicity against human RKO cells expressing wild type p53 assessed as cell viability after 5 days by MTT assay Homo sapiens 400.0 nM
Cytotoxicity against human SJSA1 cells expressing wild type p53 assessed as cell viability after 5 days by MTT assay Homo sapiens 300.0 nM
Cytotoxicity against human HCT116 cells expressing wild type p53 assessed as cell viability after 5 days by MTT assay Homo sapiens 500.0 nM
Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay Homo sapiens 18.0 nM
Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with p53 after 1 hr by HTRF assay Homo sapiens 18.0 nM
Inhibition of Humanized-Xenopus MDM2 (13-119 amino acids) interaction with p53 by SPR analysis Homo sapiens 220.0 nM
Antiproliferative activity against human SJSA1 cells assessed as inhibition of EdU incorporation after 1 hr by Click-iT EdU HCS assay in presence of 10% human serum Homo sapiens 581.0 nM
Binding affinity to human MDM2 by by Surface Plasmon Resonace (SPR) spectroscopy binding assay Homo sapiens 2.9 nM
Cytotoxicity against human SJSA1 cells assessed as growth inhibition after 16 hrs by EdU incorporation assay in presence of 10% human serum Homo sapiens 581.0 nM
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 11.35 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.15 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.15 %
Inhibition of MDM2 (unknown origin) by HTRF assay Homo sapiens 18.0 nM
Binding affinity to recombinant human GST-tagged HDM2 Homo sapiens 10.7 nM

Cross References

Resources Reference
ChEMBL CHEMBL2386346
DrugBank DB14793
FDA SRS Q8MI0X869M
Guide to Pharmacology 9599
PDB 1F0
PubChem 57406853
SureChEMBL SCHEMBL12704861
ZINC ZINC000096270381